(Q68327269)

English

In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes

scientific article published on 01 December 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

based on heuristic

inferred from title

1 reference

10.1002/EJI.1830211212

https://api.crossref.org/works/10.1002/EJI.1830211212

28 October 2022

author name string

D. H. Lynch

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684156

28 October 2022

A. E. Namen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684156

28 October 2022

R. E. Miller

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684156

28 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1684156

28 October 2022

publication date

1 December 1991

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830211212

1 reference

10.1002/EJI.1830211212

https://api.crossref.org/works/10.1002/EJI.1830211212

28 October 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830211212

1 reference

10.1002/EJI.1830211212

https://api.crossref.org/works/10.1002/EJI.1830211212

28 October 2022

European Journal of Immunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

2977-2985

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Primary and secondaryin vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-mediated immune response to syngeneic ultraviolet-induced tumors. II. The properties and antigenic specificities of cytotoxic T lymphocytes generated in vitro following removal from syngeneic tumor-immunized mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphokine purification by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of B-cell progenitors by cloned murine interleukin-7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell and mast cell lines respond to B-cell stimulatory factor 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 4 (IgG1 induction factor): a multifunctional lymphokine acting also on T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211212

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer Research

7

45

1657

author name string

Shu

publication date

1985

1 reference

10.1002/EJI.1830211212

https://api.crossref.org/works/10.1002/EJI.1830211212

28 October 2022

Cancer Research

18

49

5979

author name string

Yi Li

publication date

1989

1 reference

10.1002/EJI.1830211212

https://api.crossref.org/works/10.1002/EJI.1830211212

28 October 2022

Identifiers

10.1002/EJI.1830211212

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684156%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68327269&oldid=1759892874"